{"doi":"10.1182/blood.v95.1.164","title":"Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation","abstract":"<jats:title>Abstract</jats:title><jats:p>Binding of the adhesive glycoprotein, von Willebrand factor (vWf), to the platelet membrane glycoprotein (GP) Ib-IX-V complex initiates platelet adhesion and aggregation at high shear stress in hemostasis and thrombosis. In this study, the GP Ib-IX-V binding site within the vWf A1 domain was analyzed using a panel of murine monoclonal antibodies raised against a 39/34-kd vWf fragment (Leu-480/Val-481–Gly-718) encompassing the A1 domain. One antibody, 6G1, strongly inhibited ristocetin-dependent vWf binding to platelets, but had no effect on botrocetin- or jaracetin-dependent binding, or asialo-vWf–dependent platelet aggregation. The 6G1 epitope was mapped to Glu-700–Asp-709, confirming the importance of this region for modulation of vWf by ristocetin. Like ristocetin, 6G1 activated the vWf A1 domain, because it enhanced binding of the 39/34-kd fragment to platelets. In contrast, 5D2 and CR1 completely inhibited asialo-vWf–induced platelet aggregation and ristocetin-induced vWf binding to GP Ib-IX-V. However, only 5D2 blocked botrocetin- and jaracetin-induced vWf binding to platelets and binding of vWf to botrocetin- and jaracetin-coated beads. Epitopes for 5D2 and CR1 were conformationally dependent, but not congruent. Other antibodies mapped to epitopes within the A1 domain (CR2 and CR15, Leu-494–Leu-512; CR2, Phe-536–Ala-554; CR3, Arg-578–Glu-596; CR11 and CR15, Ala-564–Ser-582) were not functional, identifying regions of the vWf A1 domain not directly involved in vWf-GP Ib-IX-V interaction. The combined results provide evidence that the proline-rich sequence Glu-700–Asp-709 constitutes a regulatory site for ristocetin, and that ristocetin and botrocetin induce, at least in part, separate receptor-recognition sites on vWf. (Blood. 2000;95:164-172)</jats:p>","journal":"Blood","year":2000,"id":663390,"datarank":0.6456097639806255,"base_score":4.304065093204169,"endowment":4.304065093204169,"self_citation_contribution":0.6456097639806255,"citation_network_contribution":0.0,"self_endowment_contribution":0.6456097639806255,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":73,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":192615,"name":"David A. Facey","orcid":null,"position":1,"is_corresponding":false},{"id":104070,"name":"Emmanuel J. Favaloro","orcid":"0000-0002-2103-1661","position":2,"is_corresponding":false},{"id":192616,"name":"Mark S. Hertzberg","orcid":null,"position":3,"is_corresponding":false},{"id":192617,"name":"James C. Whisstock","orcid":null,"position":4,"is_corresponding":false},{"id":192618,"name":"Tracy McNally","orcid":null,"position":5,"is_corresponding":false},{"id":192619,"name":"Robert K. Andrews","orcid":"0000-0001-9577-8082","position":6,"is_corresponding":false},{"id":179112,"name":"Michael C. Berndt","orcid":null,"position":7,"is_corresponding":false},{"id":192614,"name":"Mariagrazia De Luca","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation","abstract":"<jats:title>Abstract</jats:title><jats:p>Binding of the adhesive glycoprotein, von Willebrand factor (vWf), to the platelet membrane glycoprotein (GP) Ib-IX-V complex initiates platelet adhesion and aggregation at high shear stress in hemostasis and thrombosis. In this study, the GP Ib-IX-V binding site within the vWf A1 domain was analyzed using a panel of murine monoclonal antibodies raised against a 39/34-kd vWf fragment (Leu-480/Val-481–Gly-718) encompassing the A1 domain. One antibody, 6G1, strongly inhibited ristocetin-dependent vWf binding to platelets, but had no effect on botrocetin- or jaracetin-dependent binding, or asialo-vWf–dependent platelet aggregation. The 6G1 epitope was mapped to Glu-700–Asp-709, confirming the importance of this region for modulation of vWf by ristocetin. Like ristocetin, 6G1 activated the vWf A1 domain, because it enhanced binding of the 39/34-kd fragment to platelets. In contrast, 5D2 and CR1 completely inhibited asialo-vWf–induced platelet aggregation and ristocetin-induced vWf binding to GP Ib-IX-V. However, only 5D2 blocked botrocetin- and jaracetin-induced vWf binding to platelets and binding of vWf to botrocetin- and jaracetin-coated beads. Epitopes for 5D2 and CR1 were conformationally dependent, but not congruent. Other antibodies mapped to epitopes within the A1 domain (CR2 and CR15, Leu-494–Leu-512; CR2, Phe-536–Ala-554; CR3, Arg-578–Glu-596; CR11 and CR15, Ala-564–Ser-582) were not functional, identifying regions of the vWf A1 domain not directly involved in vWf-GP Ib-IX-V interaction. The combined results provide evidence that the proline-rich sequence Glu-700–Asp-709 constitutes a regulatory site for ristocetin, and that ristocetin and botrocetin induce, at least in part, separate receptor-recognition sites on vWf. (Blood. 2000;95:164-172)</jats:p>","is_dataset_classified":null,"base_score":4.304065093204169,"endowment":4.304065093204169,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"10607699","pmcid":null,"openalex_id":"https://openalex.org/W2255702606","authors":[],"funders":[],"total_grants":0,"fwci":1.6419,"citation_percentile":0.83482649,"influential_citations":0,"citation_trend":[{"year":2012,"count":5},{"year":2014,"count":3},{"year":2015,"count":6},{"year":2016,"count":2},{"year":2017,"count":4},{"year":2018,"count":2},{"year":2019,"count":2},{"year":2020,"count":1},{"year":2021,"count":1},{"year":2023,"count":2},{"year":2024,"count":3},{"year":2025,"count":1},{"year":2026,"count":3}],"oa_status":"closed","license":null,"oa_locations":[{"url":"http://ashpublications.org/blood/article-pdf/95/1/164/1660150/164.pdf","host_type":"publisher"},{"url":"https://doi.org/10.1182/blood.v95.1.164","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/10607699","host_type":"repository"}],"fields_of_study":["Platelet Disorders and Treatments","Blood groups and transfusion","Heparin-Induced Thrombocytopenia and Thrombosis"],"mesh_terms":["Bothrops jararaca Venom","Amino Acid Sequence","Animals","Antibodies, Monoclonal","Epitopes","Binding Sites","Binding Sites, Antibody","Crotalid Venoms","Hemagglutinins","Humans","Metalloendopeptidases","Models, Molecular","Molecular Sequence Data","Peptide Fragments","Platelet Aggregation","Platelet Aggregation Inhibitors","Protein Conformation","Ristocetin","von Willebrand Factor","Protein Structure, Secondary","Platelet Glycoprotein GPIb-IX Complex","Mice"],"keywords":["Ristocetin","Platelet membrane glycoprotein","Von Willebrand factor","Platelet","Glycoprotein Ib","Epitope","Platelet Glycoprotein GPIb-IX Complex","Chemistry","Glycoprotein","Molecular biology","Monoclonal antibody","Binding site","Platelet activation","Antibody","Biochemistry","Biology","Immunology"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-12T21:33:58.727654Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}